Does BLEOMYCIN Cause Disseminated intravascular coagulation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Disseminated intravascular coagulation have been filed in association with BLEOMYCIN (Bleomycin). This represents 0.1% of all adverse event reports for BLEOMYCIN.
9
Reports of Disseminated intravascular coagulation with BLEOMYCIN
0.1%
of all BLEOMYCIN reports
4
Deaths
4
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From BLEOMYCIN?
Of the 9 reports, 4 (44.4%) resulted in death, 4 (44.4%) required hospitalization, and 4 (44.4%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does BLEOMYCIN Cause?
Off label use (656)
Febrile neutropenia (632)
Neutropenia (433)
Drug ineffective (395)
Pyrexia (291)
Product use in unapproved indication (280)
Pulmonary toxicity (263)
Thrombocytopenia (260)
Nausea (255)
Anaemia (252)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which BLEOMYCIN Alternatives Have Lower Disseminated intravascular coagulation Risk?
BLEOMYCIN vs BLINATUMOMAB
BLEOMYCIN vs BLONANSERIN
BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLEOMYCIN vs BOCEPREVIR
BLEOMYCIN vs BOCOCIZUMAB